Details
Title
How Common is Subsequent Central Nervous System (CNS) Toxicity in Patients With Hematologic Malignancy (HM) and Supratherapeutic Voriconazole (VRC) Serum Levels?
Author
Sang Taek Heo 1 ; Aitken, Samuel L 2 ; Tverdek, Frank P 2 ; Kontoyiannis, Dimitrios P 3
1 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M .D. Anderson Cancer Center, Houston, TX; Internal Medicine, Jeju National University School of Medicine, Jeju Special-Governing Province, South Korea
2 Division of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, TX
3 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M .D. Anderson Cancer Center, Houston, TX
1 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M .D. Anderson Cancer Center, Houston, TX; Internal Medicine, Jeju National University School of Medicine, Jeju Special-Governing Province, South Korea
2 Division of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, TX
3 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M .D. Anderson Cancer Center, Houston, TX
Publication year
2016
Publication date
Fall 2016
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171126559
Copyright
© The Author 2016. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.